Oleoylethanolamide

• Description :

  Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis.

• Product Name Alternative :

  N-Oleoylethanolamide; Oleamide MEA; Oleic acid monoethanolamide

• UNSPSC :

  12352211

• Hazard Statement :

  H315, H319, H320

• Target :

  Endogenous Metabolite; PPAR

• Type :

  Natural Products

• Related Pathways :

  Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Metabolic Disease; Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/Oleoylethanolamide.html

• Concentration :

  10mM

• Purity :

  98.19

• Solubility :

  DMSO : 20.83 mg/mL (ultrasonic)

• Smiles :

  CCCCCCCC/C=C\CCCCCCCC(NCCO)=O

• Molecular Formula :

  C20H39NO2

• Molecular Weight :

  325.53

• Precautions :

  H315, H319, H320

• References & Citations :

  [1]Chen L, et al. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells. Oncotarget. 2015 Dec 15;6 (40) :42530-40

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• Isoform :

  Human Endogenous Metabolite; PPARα

• CAS Number :

  [111-58-0]